[1] |
World Health Organization.Guidelines for the programmatic management of drug-resistant tuberculosis[J]. Geneva:WHO,2011.
|
[2] |
NAHID P,DORMAN S E,ALIPANAH N,et al.Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines:treatment of drug-susceptible tuberculosis[J]. Clin Infect Dis,2016,63(7):e147-e195.
|
[3] |
ZHANG Y,MITCHISON D.The curious characteristics of pyrazinamide:a review[J]. Int J Tuberc Lung Dis,2003,7(1):6-21.
|
[4] |
洪创跃,刘小立,王峰. 耐吡嗪酰胺结核分枝杆菌快速检测方法的研究进展[J]. 中华结核和呼吸杂志,2012,35(3):210-212.
|
[5] |
ZHANG Y,PERMAR S,SUN Z.Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide[J]. J Med Microbiol,2002,51(1):42-49.
|
[6] |
洪创跃,刘小立,桂静,等. 耐多药结核分枝杆菌pncA基因突变特征及与吡嗪酰胺耐药相关性研究[J]. 中华预防医学杂志,2012,46(5):436-439.
|
[7] |
XU P,WU J,YANG C,et al.Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in China[J]. Tuberculosis(Edinb),2016,98:56-61.
|
[8] |
PARSONS L M,SOMOSKÖVI A,URBANCZIK R,et al. Laboratory diagnostic aspects of drug resistant tuberculosis[J]. Front Biosci,2004,9:2086-2105.
|
[9] |
Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria,nocardiae,and othe raerobic actinomycets[S]. M24-A2,CLSI,2011.
|
[10] |
CUI Z,WANG J,LU J,et al.Evaluation of methods for testing the susceptibility of clinical Mycobacterium tuberculosis isolates to pyrazinamide[J]. J Clin Microbiol,2013,51(5):1374-1380.
|
[11] |
PIERSIMONI C,MUSTAZZOLU A,GIANNONI F,et al.Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the Bactec MGIT 960 system using a reduced inoculum[J]. J Clin Microbiol,2013,51(1):291-294.
|
[12] |
WAYNE L G.Simple pyrazinamidase and urease tests for routine identification of mycobacteria[J]. Am Rev Respir Dis,1974,109(1):147-151.
|
[13] |
SINGH P,WESLEY C,JADAUN G P,et al.Comparative evaluation of Löwenstein-Jensen proportion method,BacT/ALERT 3D system,and enzymatic pyrazinamidase assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis[J]. J Clin Microbiol,2007,45(1):76-80.
|
[14] |
CHEDORE P,BERTUCCI L,WOLFE J,et al.Potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide[J]. J Clin Microbiol,2010,48(1):300-301.
|
[15] |
SHI W,ZHANG X,JIANG X,et al.Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis[J]. Science,2011,333(6049):1630-1632.
|
[16] |
SHI W,CHEN J,FENG J,et al.Aspartate decarboxylase(PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis[J]. Emerg Microbes Infect,2014,3(8): e58.
|